Chronic Fatigue Syndrome Trial, Recruiting NCT06142253 Sponsor: VA Office of Research and Development Condition: Chronic Fatigue Syndrome
Back to Chronic Fatigue Syndrome

Chronic Fatigue Syndrome Trial, Recruiting

NCT06142253
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are a Veteran between 18 and 89 years old, of any racial or ethnic background
  • You have had a confirmed COVID-19 infection, diagnosed at least 6 months ago, with that diagnosis recorded in your medical records
  • You have had ongoing brain-related symptoms (such as "brain fog" or memory and thinking problems) that started within 3 months of getting COVID-19 and have lasted at least 8 weeks
  • You are able to see and hear well enough to complete thinking and memory tests
  • You are willing to take part in the trial for 8 months
  • Your primary care doctor has approved you to take part in water-based exercise (such as pool exercise)

Who may not be able to join:

  • You currently have a severe, uncontrolled mental health condition involving psychosis, as determined by a specific psychiatric interview tool
  • You had a neurological condition (such as multiple sclerosis, seizures, or stroke), a brain-degenerating disease (such as Parkinson's or Alzheimer's), or a serious illness affecting brain function (such as liver failure, kidney failure, heart failure, or cancer) before your COVID-19 diagnosis
  • You currently have a serious heart condition, such as uncontrolled irregular heartbeat, uncontrolled dangerous heart rhythms, active heart inflammation, severe heart failure, blood clots in the veins, a lung condition that causes your oxygen levels to drop dangerously during exercise, or a blood clot that has travelled to the lungs within the past 6 months (confirm with trial site)
  • You are unable to take part in an exercise stress test
  • You are unable to read, show that you understand, and sign the consent form on your own

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jennifer Kaci Fairchild, PhD, VA Palo Alto Health Care System, Palo Alto, CA

Phone: (650) 439-5000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility of Intervention Measure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov